|
Ros-Bernal F, Hunot S, Herrero MT, Parnadeau S, Corvol JC, Lu L, Alvarez-Fischer D, Carrillo-de Sauvage MA, Saurini F, Coussieu C, Kinugawa K, Prigent A, Höglinger G, Hamon M, Tronche F, Hirsch EC, Vyas S. Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6632-7. doi: 10.1073/pnas.1017820108. Epub 2011 Apr 5. PubMed PMID: 21467220; PubMed Central PMCID: PMC3080980.
AÑO: 2011; IF: 9.681
|
21467220
|
Zinger A, Barcia C, Herrero MT, Guillemin GJ. The involvement of neuroinflammation and kynurenine pathway in Parkinson's disease. Parkinsons Dis. 2011;2011:716859. doi: 10.4061/2011/716859. Epub 2011 Jun 3. PubMed PMID: 21687761; PubMed Central PMCID: PMC3109408.
AÑO: 2011
|
|
Herrero MT, Pagonabarraga J, Linazasoro G. Neuroprotective role of dopamine agonists: evidence from animal models and clinical studies. Neurologist. 2011 Nov;17(6 Suppl 1):S54-66. doi: 10.1097/NRL.0b013e31823968fc. Review. PubMed PMID: 22045327.
AÑO: 2011; IF: 1.261
|
|
Martín-Fernández JJ, Carles-Díes R, Cañizares F, Parra S, Avilés F, Villegas I, Morsi-Hassan O, Fernández-Barreiro A, Herrero MT. [Homocysteine and cognitive impairment in Parkinson's disease]. Rev Neurol. 2010 Feb 1-15;50(3):145-51. Spanish. PubMed PMID: 20146187.
AÑO: 2010; IF: 1.218
|
|
Esteve-Rudd J, Campello L, Herrero MT, Cuenca N, Martín-Nieto J. Expression in the mammalian retina of parkin and UCH-L1, two components of the ubiquitin-proteasome system. Brain Res. 2010 Sep 17;1352:70-82. doi: 10.1016/j.brainres.2010.07.019. Epub 2010 Jul 15. PubMed PMID: 20638372.
AÑO: 2010; IF: 2.623
|